Publications by authors named "Alwin Krämer"

4Publications

Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial.

Authors:
Mathias Witzens-Harig Monika Reiz Christiane Heiss Axel Benner Manfred Hensel Kai Neben Peter Dreger Alwin Kraemer Anthony D Ho

Ann Hematol 2009 Jan 30;88(1):51-7. Epub 2008 Jul 30.

Department of Internal Medicine V, University Hospital of Heidelberg, INF 410, 69120 Heidelberg, Germany.

View Article and Find Full Text PDF
January 2009

Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma.

Authors:
Eugen Leo Lars Scheuer Ingo G H Schmidt-Wolf Mohammed Kerowgan Christina Schmitt Albrecht Leo Tanja Baumbach Alwin Kraemer Ulrich Mey Axel Benner Reza Parwaresch Anthony D Ho

Eur J Haematol 2004 Oct;73(4):251-7

Department of Hematology-Oncology & Rheumatology, University of Heidelberg Medical Center, Germany.

View Article and Find Full Text PDF
October 2004

Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma.

Authors:
Kai Neben Thomas Moehler Axel Benner Alwin Kraemer Gerlinde Egerer Anthony D Ho Hartmut Goldschmidt

Clin Cancer Res 2002 Nov;8(11):3377-82

Department of Internal Medicine V, University of Heidelberg, 69115 Heidelberg, Germany.

View Article and Find Full Text PDF
November 2002

Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma.

Authors:
Kai Neben Joannis Mytilineos Thomas M Moehler Astrid Preiss Alwin Kraemer Anthony D Ho Gerhard Opelz Hartmut Goldschmidt

Blood 2002 Sep;100(6):2263-5

Department of Internal Medicine V, University of Heidelberg, Hospitalstrasse 3, 69115 Heidelberg, Germany.

View Article and Find Full Text PDF
September 2002